Published 2020
| Version v1
Publication
Very Short vs. Long Dual Antiplatelet Therapy after Second Generation Drug-eluting Stents in 35,785 Patients undergoing Percutaneous Coronary Interventions: a Meta-analysis of Randomised Controlled Trials
Description
To provide an updated assessment of the efficacy-safety profile of very short (1 or 3 months) dual antiplatelet therapy (DAPT) compared to long (12 months) DAPT in patients undergoing percutaneous coronary interventions (PCI).
Additional details
Identifiers
- URL
- http://hdl.handle.net/11567/1009435
- URN
- urn:oai:iris.unige.it:11567/1009435
Origin repository
- Origin repository
- UNIGE